Advertisement

A Practical Review of the Presentation, Diagnosis, and Management of Cutaneous B-Cell Lymphomas

Published:October 27, 2022DOI:https://doi.org/10.1016/j.det.2022.07.014

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bradford P.T.
        • Devesa S.S.
        • Anderson W.F.
        • et al.
        Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.
        Blood. 2009; 113: 5064-5073
        • Willemze R.
        • Cerroni L.
        • Kempf W.
        • et al.
        The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.
        Blood. 2019; 133: 1703-1714
        • Ponzoni M.
        • Campo E.
        • Nakamura S.
        Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks.
        Blood. 2018; 132: 1561-1567
        • Dojcinov S.D.
        • Venkataraman G.
        • Raffeld M.
        • et al.
        EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression.
        Am J Surg Pathol. 2010; 34: 405-417
        • Kim Y.H.
        • Willemze R.
        • Pimpinelli N.
        • et al.
        TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).
        Blood. 2007; 110: 479-484
      1. Network NCC. Primary cutaneous lymphomas. Version 1.
        (Available at:) (Accessed Jan 26, 2022)
        • O’Leary D.
        • Goyal N.
        • Rubin N.
        • et al.
        Characterization of Primary and Secondary Cutaneous B-Cell Lymphomas: a Population-Based Study of 4758 patients.
        Clin Lymphoma Myeloma Leuk, 2021
        • Hoefnagel J.J.
        Primary Cutaneous Marginal Zone B-Cell Lymphoma.
        Arch Dermatol. 2005; 141: 1139
        • Servitje O.
        • Muniesa C.
        • Benavente Y.
        • et al.
        Primary cutaneous marginal zone B-cell lymphoma: Response to treatment and disease-free survival in a series of 137 patients.
        J Am Acad Dermatol. 2013; 69: 357-365
        • Edinger J.T.
        • Kant J.A.
        • Swerdlow S.H.
        Cutaneous Marginal Zone Lymphomas Have Distinctive Features and Include 2 Subsets.
        Am J Surg Pathol. 2010; 34: 1830-1841
        • Carlsen E.D.
        • Swerdlow S.H.
        • Cook J.R.
        • et al.
        Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases.
        Am J Surg Pathol. 2019; 43: 1403-1412
        • Gibson S.E.
        • Swerdlow S.H.
        How I Diagnose Primary Cutaneous Marginal Zone Lymphoma.
        Am J Clin Pathol. 2020; 154: 428-449
        • Perry A.
        • Vincent B.J.
        • Parker S.R.S.
        Intralesional corticosteroid therapy for primary cutaneous B-cell lymphoma.
        Br J Dermatol. 2010; 163: 223-225
        • Olsen S.
        • Burdick J.F.
        • Keown P.A.
        • et al.
        Primary acute renal failure (“acute tubular necrosis”) in the transplanted kidney: morphology and pathogenesis.
        Medicine (Baltimore). 1989; 68: 173-187
        • Hamilton S.N.
        • Wai E.S.
        • Tan K.
        • et al.
        Treatment and Outcomes in Patients With Primary Cutaneous B-Cell Lymphoma: The BC Cancer Agency Experience.
        Int J Radiat Oncol. 2013; 87: 719-725
        • Kheterpal M.
        • Mehta-Shah N.
        • Virmani P.
        • et al.
        Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.
        Curr Hematol Malig Rep. 2016; 11: 224-233
        • Senff N.J.
        Results of Radiotherapy in 153 Primary Cutaneous B-Cell Lymphomas Classified According to the WHO-EORTC Classification.
        Arch Dermatol. 2007; 143: 1520
        • Goyal A.
        • Carter J.B.
        • Pashtan I.
        • et al.
        Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: A retrospective study.
        J Am Acad Dermatol. 2018; 78: 408-410
        • Amitay-Laish I.
        • Tavallaee M.
        • Kim J.
        • et al.
        Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart?.
        Br J Dermatol. 2017; 176: 1010-1020
        • van Maldegem F.
        • van Dijk R.
        • Wormhoudt T.A.M.
        • et al.
        The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment.
        Blood. 2008; 112: 3355-3361
        • Walsh N.M.
        • Lano I.M.
        • Green P.
        • et al.
        Amyloidoma of the Skin/Subcutis.
        Am J Surg Pathol. 2017; 41: 1069-1076
        • Skala S.L.
        • Hristov B.
        • Hristov A.C.
        Primary Cutaneous Follicle Center Lymphoma.
        Arch Pathol Lab Med. 2018; 142: 1313-1321
        • Bekkenk M.W.
        • Vermeer M.H.
        • Geerts M.-L.
        • et al.
        Treatment of Multifocal Primary Cutaneous B-Cell Lymphoma: A Clinical Follow-Up Study of 29 Patients.
        J Clin Oncol. 1999; 17: 2471
        • Suárez A.L.
        • Pulitzer M.
        • Horwitz S.
        • et al.
        Primary cutaneous B-cell lymphomas.
        J Am Acad Dermatol. 2013; 69: 329.e1-329.e13
        • Willemze R.
        Primary cutaneous B-cell lymphomas.
        Belgian J Hematol. 2017; 8: 213-221
        • Zhou X.A.
        • Yang J.
        • Ringbloom K.G.
        • et al.
        Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
        Blood Adv. 2021; 5: 649-661
        • Schrader A.M.R.
        • Jansen P.M.
        • Vermeer M.H.
        • et al.
        High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
        Am J Surg Pathol. 2018; 42: 1488-1494
        • Hoefnagel J.J.
        • Dijkman R.
        • Basso K.
        • et al.
        Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.
        Blood. 2005; 105: 3671-3678
        • Koens L.
        • Zoutman W.H.
        • Ngarmlertsirichai P.
        • et al.
        Nuclear Factor-κB Pathway–Activating Gene Aberrancies in Primary Cutaneous Large B-Cell Lymphoma, Leg Type.
        J Invest Dermatol. 2014; 134: 290-292
        • Pham-Ledard A.
        • Beylot-Barry M.
        • Barbe C.
        • et al.
        High Frequency and Clinical Prognostic Value of MYD88 L265P Mutation in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type.
        JAMA Dermatol. 2014; 150: 1173
        • Pham-Ledard A.
        • Cappellen D.
        • Martinez F.
        • et al.
        MYD88 Somatic Mutation Is a Genetic Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
        J Invest Dermatol. 2012; 132: 2118-2120
        • Grange F.
        • Joly P.
        • Barbe C.
        • et al.
        Improvement of Survival in Patients With Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, in France.
        JAMA Dermatol. 2014; 150: 535
        • Joly P.
        • Vasseur E.
        • Esteve E.
        • et al.
        Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases.
        Br J Dermatol. 2006; 132: 506-512
        • Brice P.
        • Cazals D.
        • Mounier N.
        • et al.
        Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas.
        Leukemia. 1998; 12: 213-219
        • Xie Y.
        • Pittaluga S.
        • Jaffe E.S.
        The Histological Classification of Diffuse Large B-cell Lymphomas.
        Semin Hematol. 2015; 52: 57-66
        • Kraft R.M.
        • Ansell S.M.
        • Villasboas J.C.
        • et al.
        Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.
        J Clin Oncol. 2021; 39: e19547
        • Senff N.J.
        • Zoutman W.H.
        • Vermeer M.H.
        • et al.
        Fine-Mapping Chromosomal Loss at 9p21: Correlation with Prognosis in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
        J Invest Dermatol. 2009; 129: 1149-1155
        • Zhou X.A.
        • Louissaint A.
        • Wenzel A.
        • et al.
        Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
        J Invest Dermatol. 2018; 138: 2365-2376
        • Pham-Ledard A.
        • Prochazkova-Carlotti M.
        • Andrique L.
        • et al.
        Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma.
        Mod Pathol. 2014; 27: 402-411
        • Yu B.
        • Zhou X.
        • Li B.
        • et al.
        FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma.
        Ann Hematol. 2011; 90: 701-708
      2. Liu Z, Zhang Y, Zhu Y, et al. <p>Prognosis of Intravascular Large B Cell Lymphoma (IVLBCL): Analysis of 182 Patients from Global Case Series</p>. Cancer Manag Res. 2020;Volume 12:10531–10540.

        • Ponzoni M.
        • Ferreri A.J.M.
        Intravascular lymphoma: a neoplasm of ‘homeless’ lymphocytes?.
        Hematol Oncol. 2006; 24: 105-112
        • Brunet V.
        • Marouan S.
        • Routy J.-P.
        • et al.
        Retrospective study of intravascular large B-cell lymphoma cases diagnosed in Quebec.
        Medicine (Baltimore). 2017; 96e5985
        • Ponzoni M.
        • Ferreri A.J.M.
        • Campo E.
        • et al.
        Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting.
        J Clin Oncol. 2007; 25: 3168-3173
        • Ferreri A.J.M.
        • Campo E.
        • Seymour J.F.
        • et al.
        Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1.
        Br J Haematol. 2004; 127: 173-183
        • Murase T.
        • Nakamura S.
        • Kawauchi K.
        • et al.
        An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome.
        Br J Haematol. 2000; 111: 826-834
        • Satoh S.
        • Yamazaki M.
        • Yahikozawa H.
        • et al.
        Intravascular large B cell lymphoma diagnosed by senile angioma biopsy.
        Intern Med. 2003; 42: 117-120
      3. Adachi Y, Kosami K, Mizuta N, et al. Benefits of skin biopsy of senile hemangioma in intravascular large B-cell lymphoma: A case report and review of the literature. Oncol Lett. 2014;7(6):2003–2006.

        • Matsue K.
        • Abe Y.
        • Kitadate A.
        • et al.
        Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma.
        Blood. 2019; 133: 1257-1259
        • Asada N.
        • Odawara J.
        • Kimura S.
        • et al.
        Use of Random Skin Biopsy for Diagnosis of Intravascular Large B-Cell Lymphoma.
        Mayo Clin Proc. 2007; 82: 1525-1527
      4. Kiyohara T, Kumakiri M, Kobayashi H, et al. A case of intravascular large B-cell lymphoma mimicking erythema nodosum: the importance of multiple skin biopsies. J Cutan Pathol. 2000;27(8):413–418.

        • Ikeda T.
        • Gion Y.
        • Yoshino T.
        • et al.
        A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspects.
        J Clin Exp Hematop. 2019; 59: 64-71
        • Lima M.
        Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
        An Bras Dermatol. 2015; 90: 687-706
        • Willemze R.
        WHO-EORTC classification for cutaneous lymphomas.
        Blood. 2005; 105: 3768-3785
        • Goyal A.
        • O’Leary D.
        • Foreman R.K.
        • et al.
        Assessing the diagnosis of “primary cutaneous mantle cell lymphoma”: A systematic review and population-based analysis.
        J Am Acad Dermatol. 2021;
        • Dhull A.K.
        • Soni A.
        • Kaushal V.
        Hodgkin’s lymphoma with cutaneous involvement.
        Case Rep. 2012; (bcr2012007599): 2012
        • Thakkar D.
        • Lipi L.
        • Misra R.
        • et al.
        Skin involvement in Burkitt’s lymphoma.
        Hematol Oncol Stem Cell Ther. 2018; 11: 251-252
        • Vachhani P.
        • Neppalli V.T.
        • Cancino C.J.
        • et al.
        Radiological imaging and bone marrow biopsy in staging of cutaneous B-cell lymphoma.
        Br J Haematol. 2019; 184: 674-676
        • Quereux G.
        • Frot A.S.
        • Brocard A.
        • et al.
        Routine bone marrow biopsy in the initial evaluation of primary cutaneous B-cell lymphoma does not appear justified.
        Eur J Dermatol. 2009; 19: 216-220
        • Goyal A.
        • Goyal K.
        • Bohjanen K.
        Mortality in intravascular large B-cell lymphoma: A SEER analysis.
        J Am Acad Dermatol. 2018; 79: 1163-1165
      5. Carter JB. Atlas of Cutaneous Lymphomas. Atlas of Cutaneous Lymphomas. 2015.

        • Hoefnagel J.J.
        • Mulder M.M.S.
        • Dreef E.
        • et al.
        Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma.
        Mod Pathol. 2006; 19: 1270-1276
        • Murase T.
        • Yamaguchi M.
        • Suzuki R.
        • et al.
        Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.
        Blood. 2007; 109: 478-485
        • Maurus K.
        • Appenzeller S.
        • Roth S.
        • et al.
        Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma.
        J Invest Dermatol. 2018; 138: 1573-1581
        • Visco C.
        • Tanasi I.
        • Quaglia F.M.
        • et al.
        Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice.
        Cancers (Basel). 2020; 12: 2913
        • Dijkman R.
        • Tensen C.P.
        • Jordanova E.S.
        • et al.
        Array-Based Comparative Genomic Hybridization Analysis Reveals Recurrent Chromosomal Alterations and Prognostic Parameters in Primary Cutaneous Large B-Cell Lymphoma.
        J Clin Oncol. 2006; 24: 296-305
        • Dijkman R.
        • Tensen C.P.
        • Buettner M.
        • et al.
        Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID.
        Blood. 2006; 107: 4926-4929
        • Chimenti S.
        • Fink-Puches R.
        • Peris K.
        • et al.
        Cutaneous involvement in lymphoblastic lymphoma.
        J Cutan Pathol. 1999; 26: 379-385
        • Ogasawara T.
        • Ebata N.
        • Hamasaki J.
        • et al.
        [BCL2, BCL6, and MYC-positive intravascular large B-cell lymphoma presenting with bilateral adrenal gland lesions].
        Rinsho Ketsueki. 2019; 60: 570-576
        • Streubel B.
        • Vinatzer U.
        • Lamprecht A.
        • et al.
        T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma.
        Leukemia. 2005; 19: 652-658
        • Mandal A.K.J.
        • Savvidou L.
        • Slater R.M.
        • et al.
        Angiotropic lymphoma: Associated chromosomal abnormalities.
        Eur J Intern Med. 2007; 18: 432-434
        • Shigematsu Y.
        • Matsuura M.
        • Nishimura N.
        • et al.
        Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation.
        Intern Med. 2016; 55: 3169-3174
        • Al-Humood S.A.
        • Al-Qallaf A.S.
        • AlShemmari S.H.
        • et al.
        Genotypic and Phenotypic Differences between Nodal and Extranodal Diffuse Large B-Cell Lymphomas.
        J Histochem Cytochem. 2011; 59: 918-931
        • Dojcinov S.
        • Fend F.
        • Quintanilla-Martinez L.
        EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.
        Pathogens. 2018; 7: 28
        • Ikeda T.
        • Gion Y.
        • Sakamoto M.
        • et al.
        Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer.
        Mod Pathol. 2020; 33: 2437-2448
      6. Roberts TK, Chen X, Liao JJ. Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature. Exp Hematol Oncol. 2015;5(1):13.

        • Natkunam Y.
        • Goodlad J.R.
        • Chadburn A.
        • et al.
        EBV-Positive B-Cell Proliferations of Varied Malignant Potential.
        Am J Clin Pathol. 2017; 147: 129-152
      7. Gali V, Bleeker JS, Lynch D. Epstein-Barr Virus Positive Mucocutaneous Ulcer: A Case Report. S D Med. 2018;71(6):252–255.

        • Satou A.
        • Nakamura S.
        EBV-positive B-cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency.
        Cancer Med. 2021; 10: 6777-6785
        • Isnard P.
        • Bruneau J.
        • Sberro-Soussan R.
        • et al.
        Dissociation of humoral and cellular immune responses in kidney transplant recipients with EBV mucocutaneous ulcer.
        Transpl Infect Dis. 2021; 23